Practice Guidelines for Lipid-Based Amphotericin B in Stem Cell Transplant Recipients

Abstract

Practical guidelines are provided for the use of lipid-based AmB formulations in SCT patients who have documented or probable invasive fungal infections, are experiencing neutropenic fever, or require secondary prophylaxis for fungal infections.